ACMG 2026 | Corporate Partner Insights Session
Advancing Genetic Insight from Prenatal Screening Through Rare Disease Diagnosis
Date: Wednesday, March 11, 2026
Time: 12:15 PM - 1:15 PM ET
Address: 1 W Pratt St, Baltimore, MD 21201
Room: 343-344 | Lunch served
Explore Natera’s latest innovations transforming prenatal and rare disease care: Fetal Focus™, a single-gene NIPT for recessive and X-linked conditions, and Zenith™, our new exome and genome solution. Learn how these advancements shorten the diagnostic odyssey and provide actionable clarity for patients.
We look forward to seeing you there! RSVP to let us know if you will be attending.

Please RSVP here:

If N/A, please fill in with none.

Natera would like to send you information about our products and services. You may unsubscribe from these communications at any time.

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the tests. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.
13011 McCallen Pass, Building A Suite 100 | Austin, TX 78753 | natera.com | Do Not Share My Personal Information | Privacy Policy